While the coronavirus disease 19 (COVID-19) pandemic has transformed the medical and
scientific communites since it was first reported in late 2019, we are only beginning to …

Introduction Persisting respiratory symptoms in COVID-19 survivors may be related to
development of pulmonary fibrosis. We assessed the proportion of chest CT scans and …

Rationale: The impact of coronavirus disease (COVID-19) on patients with interstitial lung
disease (ILD) has not been established. Objectives: To assess outcomes in patients with ILD …

Background Idiopathic pulmonary fibrosis (IPF) is a complex lung disease, characterized by
progressive lung scarring. Severe COVID-19 is associated with substantial pneumonitis and …

COVID-19 is a highly contagious respiratory disease, which mainly affects the lungs.
Critically ill patients are easily complicated by cytokine storms, acute respiratory distress …

Patients with chronic lung disease (CLD) have an increased risk for severe coronavirus
disease-19 (COVID-19) and poor outcomes. Here, we analyze the transcriptomes of …

Background Approximately half of COVID-19 survivors present persisting breathlessness,
which may include development of pulmonary fibrosis. Research Question What is the …

Abstract Purpose of Review Lung fibrosis is currently thought to stem from an aberrant
wound healing response after recurring (micro) injuries in the lung epithelium, together with …

Following respiratory viral infections or local immunizations, lung resident-memory T cells
(TRM) of the CD8 lineage provide protection against the same pathogen or related …

Introduction: The COVID-19 pandemic has challenged health care across the world, not just
by the severity of the disease and the high mortality rate but also by the consequences on …